Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

Approved Marketing Authorisations (MA) containing Mepolizumab in Europe. Original Data : EMA Website

Client Email

Product

Mepolizumab
Europe

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

xyz-pharma-m-2024-09-09

Contact Supplier

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

Contact Supplier

Veranova: A CDMO that manages complexity with confidence.

Contact Supplier

xyz-pharma-m-2024-09-09

Contact Supplier

Mepolizumab

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

2 API Suppliers, 2 Listed Suppliers

2 API Suppliers
2 Listed Suppliers

DEVELOPMENTS

11 Drugs in Development

11 Drugs in Development

FINISHED DOSAGE FORMULATIONS

18 FDF Dossiers, 2 FDA Orange Book, 5 Europe, 3 Canada, 8 Australia

18 FDF Dossiers
2 FDA Orange Book
5 Europe
3 Canada
8 Australia

RELATED EXCIPIENT COMPANIES

1 Jai Radhe Sales, 1 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 3 Actylis, 1 BASF, 4 Gangwal Chemicals, 1 Nanjing Bold Chemical, 6 Seppic

1 Jai Radhe Sales
1 Nanjing Well Pharmaceutical
1 Pfanstiehl
3 Actylis
1 BASF
4 Gangwal Chemicals
1 Nanjing Bold Chemical
6 Seppic

EXCIPIENTS BY APPLICATIONS

10 Solubilizers, 6 Parenteral, 4 Thickeners and Stabilizers, 3 Topical, 3 Emulsifying Agents, 2 Film Formers & Plasticizers, 2 Taste Masking, 2 Surfactant & Foaming Agents, 2 Coating Systems & Additives, 1 Co-Processed Excipients, 1 Direct Compression, 1 Rheology Modifiers, 1 API Stability Enhancers

10 Solubilizers
6 Parenteral
4 Thickeners and Stabilizers
3 Topical
3 Emulsifying Agents
2 Film Formers & Plasticizers
2 Taste Masking
2 Surfactant & Foaming Agents
2 Coating Systems & Additives
1 Co-Processed Excipients
1 Direct Compression
1 Rheology Modifiers
1 API Stability Enhancers

DIGITAL CONTENT

4 DATA COMPILATION #PharmaFlow, 77 NEWS #PharmaBuzz

4 DATA COMPILATION #PharmaFlow
77 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 4 Finished Drug Prices, 1 Annual Reports

1 US Medicaid Prescriptions
4 Finished Drug Prices
1 Annual Reports

MARKET PLACE

1 APIs, 1 FDF Dossiers

1 APIs
1 FDF Dossiers

PATENTS & EXCLUSIVITIES

1 Health Canada Patents

1 Health Canada Patents

Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

5 All

01 4GlaxoSmithKline AG

02 1GlaxoSmithKline Trading

filter Active Ingredients Reset all filters

5 All

01 4Mepolizumabum

02 1mepolizumab

filter Dosage Form Reset all filters

5 All

01 1Dry Sub

02 3Inj L?s

03 1POWDER FOR SOLUTION FOR INJECTION

filter Country Reset all filters

5 All

01 1Sweden

02 4Switzerland

filter Brand Name Reset all filters

5 All

01 5Nucala

FDF Dossiers
FDA Orange Book
Europe
Canada
Australia

List of Suppliers

Product Main Page

01

GlaxoSmithKline AG

Boulder Peptide 2024

Not Confirmed

GlaxoSmithKline AG

Boulder Peptide 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Switzerland

Mepolizumabum

Brand Name : Nucala

Dosage Form : Dry Sub

Dosage Strength : 100mg/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

GlaxoSmithKline AG

Boulder Peptide 2024

Not Confirmed

GlaxoSmithKline AG

Boulder Peptide 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Switzerland

Mepolizumabum

Brand Name : Nucala

Dosage Form : Inj L?s

Dosage Strength : 100mg/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

GlaxoSmithKline AG

Boulder Peptide 2024

Not Confirmed

GlaxoSmithKline AG

Boulder Peptide 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Switzerland

Mepolizumabum

Brand Name : Nucala

Dosage Form : Inj L?s

Dosage Strength : 100mg/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

GlaxoSmithKline AG

Boulder Peptide 2024

Not Confirmed

GlaxoSmithKline AG

Boulder Peptide 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Switzerland

Mepolizumabum

Brand Name : Nucala

Dosage Form : Inj L?s

Dosage Strength : 100mg/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

GlaxoSmithKline Trading

Country

Boulder Peptide 2024

Not Confirmed

GlaxoSmithKline Trading

Country

Boulder Peptide 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Country

Virtual Booth

Digital Content

Regulatory Info :

Registration Country : Sweden

mepolizumab

Brand Name : Nucala

Dosage Form : POWDER FOR SOLUTION FOR INJECTION

Dosage Strength : 100 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?